Mid-Term Assessment of the EU Drugs Strategy 2013–2020 and Final Evaluation of the Action Plan on Drugs 2013–2016: Final report
The report sets out the findings of an evaluation that assesses the degree of implementation of the EU Drugs Strategy 2013-2020 and the Action Plan 2013-2016 in all 28 EU Member States in terms of outputs and, where possible, impacts.
Emilie Balbirnie, Matthew Davies, Emma Disley, Cristina Gonzalez Monsalve, Stephen Hartka, Stijn Hoorens, Kristy Kruithof, Martin Sacher, Jirka Taylor